Cargando…

Fascia Lata Alterations in Hip Osteoarthritis: An Observational Cross-Sectional Study

The present study compares the structure and composition of fascia lata in healthy subjects and in patients with hip osteoarthritis (OA), to evaluate any differences in the amount of Collagen type I, Collagen type III, and Hyaluronan. Fascia lata samples from voluntary healthy subjects and patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Fantoni, Ilaria, Biz, Carlo, Fan, Chenglei, Pirri, Carmelo, Fede, Caterina, Petrelli, Lucia, Ruggieri, Pietro, De Caro, Raffaele, Stecco, Carla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625990/
https://www.ncbi.nlm.nih.gov/pubmed/34833012
http://dx.doi.org/10.3390/life11111136
_version_ 1784606557031366656
author Fantoni, Ilaria
Biz, Carlo
Fan, Chenglei
Pirri, Carmelo
Fede, Caterina
Petrelli, Lucia
Ruggieri, Pietro
De Caro, Raffaele
Stecco, Carla
author_facet Fantoni, Ilaria
Biz, Carlo
Fan, Chenglei
Pirri, Carmelo
Fede, Caterina
Petrelli, Lucia
Ruggieri, Pietro
De Caro, Raffaele
Stecco, Carla
author_sort Fantoni, Ilaria
collection PubMed
description The present study compares the structure and composition of fascia lata in healthy subjects and in patients with hip osteoarthritis (OA), to evaluate any differences in the amount of Collagen type I, Collagen type III, and Hyaluronan. Fascia lata samples from voluntary healthy subjects and patients with OA were harvested during surgery. Collagen type I (COL I), III (COL III) antibody, and biotinylated hyaluronan binding protein (HABP) immunohistochemistry stainings were used to evaluate fascial morphology and COL I, COL III, and Hyaluronan (HA) content in both groups. Ten samples from healthy subjects and 11 samples from OA patients were collected. COL I was significantly more abundant in the OA group (p = 0.0015), with a median percentage positivity of 75.2 (IQR 13.11)%, while representing only 67 (IQR: 8.71)% in control cases. COL III, with median values of 9.5 (IQR 3.63)% (OA group) and 17.10 (IQR 11)% (control cases), respectively, showed significant reduction in OA patients (p = 0.002). HA showed a median value of 10.01 (IQR 8.11)% in OA patients, denoting significant decrease (p < 0.0001) with respect to the control group median 39.31 (IQR 5.62)%. The observed differences suggest a relationship between fascial pathology and hip OA. The observed increase in COL I in OA patients, along with the reduction of COL III and HA, could lead to fascial stiffening, which could alter fascial mechanics and be linked to the development and symptoms of OA.
format Online
Article
Text
id pubmed-8625990
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86259902021-11-27 Fascia Lata Alterations in Hip Osteoarthritis: An Observational Cross-Sectional Study Fantoni, Ilaria Biz, Carlo Fan, Chenglei Pirri, Carmelo Fede, Caterina Petrelli, Lucia Ruggieri, Pietro De Caro, Raffaele Stecco, Carla Life (Basel) Article The present study compares the structure and composition of fascia lata in healthy subjects and in patients with hip osteoarthritis (OA), to evaluate any differences in the amount of Collagen type I, Collagen type III, and Hyaluronan. Fascia lata samples from voluntary healthy subjects and patients with OA were harvested during surgery. Collagen type I (COL I), III (COL III) antibody, and biotinylated hyaluronan binding protein (HABP) immunohistochemistry stainings were used to evaluate fascial morphology and COL I, COL III, and Hyaluronan (HA) content in both groups. Ten samples from healthy subjects and 11 samples from OA patients were collected. COL I was significantly more abundant in the OA group (p = 0.0015), with a median percentage positivity of 75.2 (IQR 13.11)%, while representing only 67 (IQR: 8.71)% in control cases. COL III, with median values of 9.5 (IQR 3.63)% (OA group) and 17.10 (IQR 11)% (control cases), respectively, showed significant reduction in OA patients (p = 0.002). HA showed a median value of 10.01 (IQR 8.11)% in OA patients, denoting significant decrease (p < 0.0001) with respect to the control group median 39.31 (IQR 5.62)%. The observed differences suggest a relationship between fascial pathology and hip OA. The observed increase in COL I in OA patients, along with the reduction of COL III and HA, could lead to fascial stiffening, which could alter fascial mechanics and be linked to the development and symptoms of OA. MDPI 2021-10-25 /pmc/articles/PMC8625990/ /pubmed/34833012 http://dx.doi.org/10.3390/life11111136 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Fantoni, Ilaria
Biz, Carlo
Fan, Chenglei
Pirri, Carmelo
Fede, Caterina
Petrelli, Lucia
Ruggieri, Pietro
De Caro, Raffaele
Stecco, Carla
Fascia Lata Alterations in Hip Osteoarthritis: An Observational Cross-Sectional Study
title Fascia Lata Alterations in Hip Osteoarthritis: An Observational Cross-Sectional Study
title_full Fascia Lata Alterations in Hip Osteoarthritis: An Observational Cross-Sectional Study
title_fullStr Fascia Lata Alterations in Hip Osteoarthritis: An Observational Cross-Sectional Study
title_full_unstemmed Fascia Lata Alterations in Hip Osteoarthritis: An Observational Cross-Sectional Study
title_short Fascia Lata Alterations in Hip Osteoarthritis: An Observational Cross-Sectional Study
title_sort fascia lata alterations in hip osteoarthritis: an observational cross-sectional study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625990/
https://www.ncbi.nlm.nih.gov/pubmed/34833012
http://dx.doi.org/10.3390/life11111136
work_keys_str_mv AT fantoniilaria fascialataalterationsinhiposteoarthritisanobservationalcrosssectionalstudy
AT bizcarlo fascialataalterationsinhiposteoarthritisanobservationalcrosssectionalstudy
AT fanchenglei fascialataalterationsinhiposteoarthritisanobservationalcrosssectionalstudy
AT pirricarmelo fascialataalterationsinhiposteoarthritisanobservationalcrosssectionalstudy
AT fedecaterina fascialataalterationsinhiposteoarthritisanobservationalcrosssectionalstudy
AT petrellilucia fascialataalterationsinhiposteoarthritisanobservationalcrosssectionalstudy
AT ruggieripietro fascialataalterationsinhiposteoarthritisanobservationalcrosssectionalstudy
AT decaroraffaele fascialataalterationsinhiposteoarthritisanobservationalcrosssectionalstudy
AT steccocarla fascialataalterationsinhiposteoarthritisanobservationalcrosssectionalstudy